Abstract
The COVID-19 vaccines offer protection against the severe acute respiratory syndrome Corona virus 2 (SARS-CoV-2) by developing an immune response to the same. Further, there are mass vaccination programs being conducted across the globe. India administered COVID – 19 vaccines for more than 90 crores of people as on October 2021. However, there are still a bunch of people yet to receive vaccination. Adding to this, very few are found to be allergic to COVID – 19 vaccines. Hence there is a need for an alternative approach till the whole population of the world gets vaccinated. One such approach is prescribing Nilavembu kudineer and Kabha sura kudineer, a polyherbal Siddha medicine formulation of Traditional Indian system of Medicine. This case study highlights the positive effects and importance of the above mentioned polyherbal formulations in the management of mild to moderate COVID-19 patients. Hence, the same can be advised to the individuals who are yet to receive COVID-19 vaccine and persons who are allergic to COVID -19 vaccines.
Highlights
2.2 Present Medical HistoryIndia administered more than 90 crores of COVID-19 vaccination as of mid October 2021 and it has shown promising effects with decreased morbidity and mortality rate of Coronavirus disease across the country
The Siddha medicines namely Nilavembu and Kabhasura kudineer are found to be highly effective in treating the mild to moderate COVID19 patients
Even though this case study is done in an unvaccinated patient, it can be extrapolated to the individuals who are allergic to the COVID19 vaccine
Summary
India administered more than 90 crores of COVID-19 vaccination as of mid October 2021 and it has shown promising effects with decreased morbidity and mortality rate of Coronavirus disease across the country. Among the available literature it was found that usage of Indian systems of Medicine like Siddha medicine would be a suitable candidate for patients with severe vaccine allergy as well as patients who are waiting to receive the first or second dose of COVID – 19 vaccinations. Very little effort was made to use only Siddha treatment in the management of COIVD-19 patients. In this regard, the author presents this case report (a single case study) of a mild to moderate Coronavirus disease patient in Chennai who was treated totally with Siddha medications and was completely relieved of his symptoms and the test result was negative within five days
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
